Literature DB >> 14560002

Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53.

Toshiki Itoh1, Cristin O'Shea, Stuart Linn.   

Abstract

Tumor suppressor p53 controls cell cycle progression and apoptosis following DNA damage, thus minimizing carcinogenesis. Mutations in the human DDB2 gene generate the E subgroup of xeroderma pigmentosum (XP-E). We report here that XP-E strains are defective in UV irradiation-induced apoptosis due to severely reduced basal and UV-induced p53 levels. These defects are restored by infection with a p53 cDNA expression construct or with a DDB2 expression construct if and only if it contains intron 4, which includes a nonmutated p53 consensus-binding site. We propose that both before and after UV irradiation, DDB2 directly regulates p53 levels, while DDB2 expression is itself regulated by p53.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560002      PMCID: PMC207631          DOI: 10.1128/MCB.23.21.7540-7553.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  Regulation of the p53 tumor suppressor protein.

Authors:  M Oren
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Profile of gene expression regulated by induced p53: connection to the TGF-beta family.

Authors:  K Kannan; N Amariglio; G Rechavi; D Givol
Journal:  FEBS Lett       Date:  2000-03-17       Impact factor: 4.124

3.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

4.  Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.

Authors:  E D Lustbader; W R Williams; M L Bondy; S Strom; L C Strong
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

5.  Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation.

Authors:  A F Nichols; T Itoh; J A Graham; W Liu; M Yamaizumi; S Linn
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.

Authors:  T Itoh; S Linn; T Ono; M Yamaizumi
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

7.  UVs syndrome: establishment and characterization of fibroblastic cell lines transformed with simian virus 40 DNA.

Authors:  T Itoh; M Yamaizumi
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

8.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.

Authors:  H Tanaka; H Arakawa; T Yamaguchi; K Shiraishi; S Fukuda; K Matsui; Y Takei; Y Nakamura
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

9.  p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4.

Authors:  S J Miller; T Suthiphongchai; G P Zambetti; M E Ewen
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  30 in total

1.  Ddb1 controls genome stability and meiosis in fission yeast.

Authors:  Christian Holmberg; Oliver Fleck; Heidi A Hansen; Cong Liu; Rita Slaaby; Antony M Carr; Olaf Nielsen
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

2.  DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.

Authors:  Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  DDB2, an essential mediator of premature senescence.

Authors:  Nilotpal Roy; Tanya Stoyanova; Carmen Dominguez-Brauer; Hyun Jung Park; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

4.  Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage.

Authors:  Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cell Div       Date:  2010-01-19       Impact factor: 5.130

Review 5.  UV-induced ubiquitylation of XPC complex, the UV-DDB-ubiquitin ligase complex, and DNA repair.

Authors:  Kaoru Sugasawa
Journal:  J Mol Histol       Date:  2006-07-21       Impact factor: 2.611

6.  Multiple skin cancers in adults with mutations in the XP-E (DDB2) DNA repair gene.

Authors:  Kyu-Seon Oh; Steffen Emmert; Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2010-11-25       Impact factor: 8.551

7.  Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63.

Authors:  Bridget E Ferguson-Yates; Hongyan Li; Tiffany K Dong; Jennifer L Hsiao; Dennis H Oh
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

8.  Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

Authors:  Bassant M Barakat; Qi-En Wang; Chunhua Han; Keisha Milum; De-Tao Yin; Qun Zhao; Gulzar Wani; El-Shaimaa A Arafa; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

9.  Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

Authors:  William K Kaufmann; Kathleen R Nevis; Pingping Qu; Joseph G Ibrahim; Tong Zhou; Yingchun Zhou; Dennis A Simpson; Jennifer Helms-Deaton; Marila Cordeiro-Stone; Dominic T Moore; Nancy E Thomas; Honglin Hao; Zhi Liu; Janiel M Shields; Glynis A Scott; Norman E Sharpless
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

10.  DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen.

Authors:  Toshiki Itoh; Dragana Cado; Ryoichi Kamide; Stuart Linn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.